Kissei Pharmaceutical Co., Ltd. - Product Pipeline Review

Brochure
More information from http://www.researchandmarkets.com/reports/2988450/
Kissei Pharmaceutical Co., Ltd. - Product Pipeline Review - 2014
Description:
Kissei Pharmaceutical Co., Ltd. - Product Pipeline Review - 2014
Summary
This, ‘Kissei Pharmaceutical Co., Ltd. - Product Pipeline Review - 2014’, provides an overview of the Kissei
Pharmaceutical Co., Ltd.’s pharmaceutical research and development focus.
This report provides comprehensive information on the current therapeutic developmental pipeline of Kissei
Pharmaceutical Co., Ltd.’s, complete with comparative analysis at various stages, therapeutics assessment
by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. It also reviews
latest updates, and featured news and press releases, along with special features on late-stage and
discontinued projects.
This report features investigational drugs from across globe covering over 20 therapy areas and nearly 3,000
indications. The report is built using data and information sourced from This proprietary databases,
Company/University websites, SEC filings, investor presentations and featured press releases from
company/university sites and industry-specific third party sources, put together by This team. Drug
profiles/records featured in the report undergoes periodic updation following a stringent set of processes
that ensures that all the profiles are updated with the latest set of information. Additionally, processes
including live news & deals tracking, browser based alert-box and clinical trials registries tracking ensure that
the most recent developments are captured on a real time basis.
The report enhances decision making capabilities and help to create effective counter strategies to gain
competitive advantage. It strengthens R&D pipelines by identifying new targets and MOAs to produce first-in
-class and best-in-class products.
Note*: Certain sections in the report may be removed or altered based on the availability and relevance of
data for the indicated disease.
Scope
- The report provides brief overview of Kissei Pharmaceutical Co., Ltd. including business description, key
information and facts, and its locations and subsidiaries
- The report reviews current pipeline of Kissei Pharmaceutical Co., Ltd.’s human therapeutic division and
enlists all their major and minor projects
- The report features product description and descriptive mechanism of action for key pipeline products
along with the product’s developmental history and major milestones
- Special feature on out-licensed and partnered product portfolio
- The report summarizes all the dormant and discontinued pipeline projects
- Latest company statement
- Latest news and deals relating to the Kissei Pharmaceutical Co., Ltd.’s pipeline products
Reasons to buy
- Evaluate Kissei Pharmaceutical Co., Ltd.’s strategic position with total access to detailed information on its
product pipeline
- Assess the growth potential of Kissei Pharmaceutical Co., Ltd. in its therapy areas of focus
- Identify new drug targets and therapeutic classes in the Kissei Pharmaceutical Co., Ltd.’s R&D portfolio and
develop key strategic initiatives to reinforce pipeline in those areas
- Exploit in-licensing opportunities by identifying windows of opportunity to fill portfolio gaps
- Develop strategic initiatives by understanding the focus areas of Kissei Pharmaceutical Co., Ltd. and exploit
collaboration and partnership opportunities
- Identify emerging players with potentially strong product portfolio and create effective counter-strategies
to gain competitive advantage
- Plan mergers and acquisitions effectively by identifying the most promising pipeline of Kissei
Pharmaceutical Co., Ltd.
- Develop and design in-licensing and out-licensing strategies by identifying prospective partners with the
most attractive projects to enhance and expand business potential and scope
- Explore the dormant and discontinued projects of Kissei Pharmaceutical Co., Ltd. and identify potential
opportunities in those areas
- Avoid Intellectual Property Rights related issues
Contents:
List of Tables
List of Figures
Kissei Pharmaceutical Co., Ltd. Snapshot
Kissei Pharmaceutical Co., Ltd. Overview
Key Information
Key Facts
Kissei Pharmaceutical Co., Ltd. - Research and Development Overview
Key Therapeutic Areas
Kissei Pharmaceutical Co., Ltd. - Pipeline Review
Pipeline Products by Stage of Development
Pipeline Products - Monotherapy
Pipeline Products - Combination Treatment Modalities
Pipeline Products - Partnered Products
Partnered Products/Combination Treatment Modalities
Kissei Pharmaceutical Co., Ltd. - Pipeline Products Glance
Kissei Pharmaceutical Co., Ltd. - Late Stage Pipeline Products
Pre-Registration Products/Combination Treatment Modalities
Phase III Products/Combination Treatment Modalities
Kissei Pharmaceutical Co., Ltd. - Clinical Stage Pipeline Products
Phase II Products/Combination Treatment Modalities
Phase I Products/Combination Treatment Modalities
Kissei Pharmaceutical Co., Ltd. - Early Stage Pipeline Products
Preclinical Products/Combination Treatment Modalities
Discovery Products/Combination Treatment Modalities
Kissei Pharmaceutical Co., Ltd. - Drug Profiles
mitiglinide
Product Description
Mechanism of Action
R&D Progress
KPS-0373
Product Description
Mechanism of Action
R&D Progress
sucroferric oxyhydroxide
Product Description
Mechanism of Action
R&D Progress
(remogliflozin etabonate + metformin hydrochloride)
Product Description
Mechanism of Action
R&D Progress
bedoradrine sulfate
Product Description
Mechanism of Action
R&D Progress
KLH-2109
Product Description
Mechanism of Action
R&D Progress
KUX-1151
Product Description
Mechanism of Action
R&D Progress
KWA-0711
Product Description
Mechanism of Action
R&D Progress
ozagrel
Product Description
Mechanism of Action
R&D Progress
remogliflozin etabonate
Product Description
Mechanism of Action
R&D Progress
YS-110
Product Description
Mechanism of Action
R&D Progress
KEA-0477
Product Description
Mechanism of Action
R&D Progress
AS-192426900
Product Description
Mechanism of Action
R&D Progress
AS-192781900
Product Description
Mechanism of Action
R&D Progress
AS-193280400
Product Description
Mechanism of Action
R&D Progress
KGO-2142
Product Description
Mechanism of Action
R&D Progress
KGO-2173
Product Description
Mechanism of Action
R&D Progress
KOM-1962
Product Description
Mechanism of Action
R&D Progress
KTA-439
Product Description
Mechanism of Action
R&D Progress
Small Molecules to Inhibit SGLT1 for Postprandial Hyperglycemia
Product Description
Mechanism of Action
R&D Progress
KTA-574
Product Description
Mechanism of Action
R&D Progress
Kissei Pharmaceutical Co., Ltd. - Pipeline Analysis
Kissei Pharmaceutical Co., Ltd. - Pipeline Products by Target
Kissei Pharmaceutical Co., Ltd. - Pipeline Products by Route of Administration
Kissei Pharmaceutical Co., Ltd. - Pipeline Products by Molecule Type
Kissei Pharmaceutical Co., Ltd. - Pipeline Products by Mechanism of Action
Kissei Pharmaceutical Co., Ltd. - Recent Pipeline Updates
Kissei Pharmaceutical Co., Ltd. - Dormant Projects
Kissei Pharmaceutical Co., Ltd. - Discontinued Pipeline Products
Discontinued Pipeline Product Profiles
diquafosol tetrasodium
KGA-3235
KLS-0611
remogliflozin etabonate
ritobegron
VX-745
Kissei Pharmaceutical Co., Ltd. - Company Statement
Kissei Pharmaceutical Co., Ltd. - Locations And Subsidiaries
Head Office
Other Locations & Subsidiaries
Appendix
Methodology
Coverage
Secondary Research
Primary Research
Expert Panel Validation
Contact Us
Disclaimer
List of Tables
Kissei Pharmaceutical Co., Ltd., Key Information
Kissei Pharmaceutical Co., Ltd., Key Facts
Kissei Pharmaceutical Co., Ltd. - Pipeline by Indication, 2014
Kissei Pharmaceutical Co., Ltd. - Pipeline by Stage of Development, 2014
Kissei Pharmaceutical Co., Ltd. - Monotherapy Products in Pipeline, 2014
Kissei Pharmaceutical Co., Ltd. - Combination Treatment Modalities in Pipeline, 2014
Kissei Pharmaceutical Co., Ltd. - Partnered Products in Pipeline, 2014
Kissei Pharmaceutical Co., Ltd. - Partnered Products/ Combination Treatment Modalities, 2014
Kissei Pharmaceutical Co., Ltd. - Pre-Registration, 2014
Kissei Pharmaceutical Co., Ltd. - Phase III, 2014
Kissei Pharmaceutical Co., Ltd. - Phase II, 2014
Kissei Pharmaceutical Co., Ltd. - Phase I, 2014
Kissei Pharmaceutical Co., Ltd. - Preclinical, 2014
Kissei Pharmaceutical Co., Ltd. - Discovery, 2014
Kissei Pharmaceutical Co., Ltd. - Pipeline by Target, 2014
Kissei Pharmaceutical Co., Ltd. - Pipeline by Route of Administration, 2014
Kissei Pharmaceutical Co., Ltd. - Pipeline by Molecule Type, 2014
Kissei Pharmaceutical Co., Ltd. - Pipeline Products by Mechanism of Action, 2014
Kissei Pharmaceutical Co., Ltd. - Recent Pipeline Updates, 2014
Kissei Pharmaceutical Co., Ltd. - Dormant Developmental Projects,2014
Kissei Pharmaceutical Co., Ltd. - Discontinued Pipeline Products, 2014
Kissei Pharmaceutical Co., Ltd., Other Locations
Kissei Pharmaceutical Co., Ltd., Subsidiaries
List of Figures
Kissei Pharmaceutical Co., Ltd. - Pipeline by Top 10 Indication, 2014
Kissei Pharmaceutical Co., Ltd. - Pipeline by Stage of Development, 2014
Kissei Pharmaceutical Co., Ltd. - Monotherapy Products in Pipeline, 2014
Kissei Pharmaceutical Co., Ltd. - Partnered Products in Pipeline, 2014
Kissei Pharmaceutical Co., Ltd. - Pipeline by Top 10 Target, 2014
Kissei Pharmaceutical Co., Ltd. - Pipeline by Top 10 Route of Administration, 2014
Kissei Pharmaceutical Co., Ltd. - Pipeline by Top 10 Molecule Type, 2014
Kissei Pharmaceutical Co., Ltd. - Pipeline Products by Top 10 Mechanism of Action, 2014
Ordering:
Order Online - http://www.researchandmarkets.com/reports/2988450/
Order by Fax - using the form below
Order by Post - print the order form below and send to
Research and Markets,
Guinness Centre,
Taylors Lane,
Dublin 8,
Ireland.
Page 1 of 2
Fax Order Form
To place an order via fax simply print this form, fill in the information below and fax the completed form to 646-607-1907 (from
USA) or +353-1-481-1716 (from Rest of World). If you have any questions please visit
http://www.researchandmarkets.com/contact/
Order Information
Please verify that the product information is correct and select the format(s) you require.
Product Name:
Kissei Pharmaceutical Co., Ltd. - Product Pipeline Review - 2014
Web Address:
http://www.researchandmarkets.com/reports/2988450/
Office Code:
SCE75WE1
Product Formats
Please select the product formats and quantity you require:
Quantity
Electronic (PDF) Single User:
USD 1500
Electronic (PDF) Site License:
USD 3000
Electronic (PDF) Enterprisewide:
USD 4500
Contact Information
Please enter all the information below in BLOCK CAPITALS
Title:
First Name:
Mr
Mrs
Dr
Miss
Last Name:
Email Address: *
Job Title:
Organisation:
Address:
City:
Postal / Zip Code:
Country:
Phone Number:
Fax Number:
* Please refrain from using free email accounts when ordering (e.g. Yahoo, Hotmail, AOL)
Ms
Prof
Page 2 of 2
Payment Information
Please indicate the payment method you would like to use by selecting the appropriate box.
Pay by credit card:
You will receive an email with a link to a secure webpage to enter your
credit card details.
Pay by check:
Please post the check, accompanied by this form, to:
Research and Markets,
Guinness Center,
Taylors Lane,
Dublin 8,
Ireland.
Pay by wire transfer:
Please transfer funds to:
Account number
833 130 83
Sort code
98-53-30
Swift code
ULSBIE2D
IBAN number
IE78ULSB98533083313083
Bank Address
Ulster Bank,
27-35 Main Street,
Blackrock,
Co. Dublin,
Ireland.
If you have a Marketing Code please enter it below:
Marketing Code:
Please note that by ordering from Research and Markets you are agreeing to our Terms and Conditions at
http://www.researchandmarkets.com/info/terms.asp
Please fax this form to:
(646) 607-1907 or (646) 964-6609 - From USA
+353-1-481-1716 or +353-1-653-1571 - From Rest of World

Download Report